Anti-CD40 antibodies were detected in FSGS patients and their levels were found to correlate with post-transplant recurrence of the disease (97); injection of the CD40/anti-CD40 complex induced proteinuria in mice. This evidence concerns the gene CD40 and focal segmental glomerulosclerosis.